CRMD Q4 2021 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$56,397+1.2% YoY

Gross Profit

$8,39014.9% margin

Operating Income

-$8M-13794.9% margin

Net Income

-$8M-13814.5% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+48.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$69M

Total Liabilities

$6M

Stockholders' Equity

$63M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56,397	$55,713	+1.2%
Gross Profit	$8,390	-$1,520	+652.0%
Operating Income	-$8M	-$6M	-27.9%
Net Income	-$8M	-$6M	-28.0%